Glimisave M1 750 Tablet PR is classified as an anti-diabetic medication used to treat type 2 diabetes mellitus in adults. This tablet is a combination of two drugs, Glimepiride and Metformin, aimed at helping individuals control their blood sugar levels effectively. Glimepiride functions by stimulating insulin production in the pancreas, aiding in the removal of sugar from the bloodstream. On the other hand, Metformin PR is a prolonged-release formula that lowers sugar production in the liver, delays sugar absorption from the intestines, and enhances muscle cell sensitivity to insulin, resulting in improved sugar removal from the blood.

It is crucial to consume Glimisave M1 750 Tablet PR with food consistently at the same time each day for optimum results. The dosage of the medication is determined by the doctor and may be revised based on blood sugar level monitoring. Even if the individual feels well or their blood sugar levels are regulated, it is vital to continue taking this medicine as directed. Ceasing the medication without medical advice could lead to elevated blood sugar levels, putting the individual at risk of severe complications like kidney damage, blindness, nerve issues, and limb loss.

Common side effects of Glimisave M1 750 Tablet PR include low blood glucose levels (hypoglycemia), which can be identified by symptoms such as sweating, dizziness, headache, and shaking. To prevent hypoglycemia, it is recommended to maintain regular meals and carry a quick-acting glucose source at all times. Additionally, alcohol consumption should be avoided, as it can increase the risk of low blood sugar levels. Other potential side effects may include taste changes, nausea, diarrhea, stomach pain, headache, upper respiratory tract infection, and weight gain in some individuals.

Certain precautions should be observed before taking Glimisave M1 750 Tablet PR. Individuals with type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart problems should not use this medication. Pregnant or breastfeeding women should consult their healthcare provider before initiating treatment. Regular monitoring of blood sugar levels and periodic blood tests to assess blood cell counts and liver function are advisable during the course of treatment with this medication.

Glimisave M1 750 Tablet PR, a combination medicine used in the treatment of Type 2 diabetes mellitus, offers a range of benefits to individuals managing this condition. By increasing the production of insulin in the pancreas, the medication helps to lower blood glucose levels, which is crucial in diabetes management. Regular intake of this tablet, usually once a day as prescribed, plays a significant role in controlling blood glucose levels. Managing blood glucose effectively can reduce the risk of serious complications associated with diabetes, such as kidney damage, eye damage, nerve problems, and potential loss of limbs. When used consistently alongside a proper diet and exercise routine, Glimisave M1 750 Tablet PR supports individuals in living a normal, healthy life.

The composition of Glimisave M1 750 Tablet PR includes Glimepiride and Metformin, with each ingredient contributing to the overall effectiveness of the medication. Glimepiride stimulates insulin production in the pancreas, aiding in the removal of sugar from the blood. On the other hand, Metformin PR, in its prolonged-release formulation, delivers the drug gradually over an extended period. By reducing sugar production in the liver, delaying sugar absorption from the intestines, and enhancing the sensitivity of muscle cells to insulin, Metformin helps in effectively managing blood sugar levels. The combined action of these components makes Glimisave M1 750 Tablet PR an essential tool in the management of Type 2 diabetes, promoting better health outcomes when used consistently alongside healthy lifestyle choices.

To use Glimisave M1 750 Tablet PR, always follow your doctor's instructions or read the label carefully before using. It is important to take Glimisave M1 750 Tablet PR with food. When taking Glimisave M1 750 Tablet PR, swallow the tablet whole with a glass of water. Do not crush or break the tablet. Similarly, when taking Glimisave M1 750 Tablet PR, swallow it with water without crushing or chewing it. Your physician will determine the right dosage and duration based on factors like your age, weight, and health condition. It is crucial not to stop taking Glimisave M1 750 Tablet PR without consulting your doctor to ensure the best results.

Glimisave M1 750 Tablet PR is commonly utilized as a treatment for Type 2 diabetes mellitus. It is specifically designed to help manage this type of diabetes when traditional methods like diet, exercise, and single-agent therapy do not achieve sufficient control of blood sugar levels. By incorporating Glimisave M1 750 Tablet PR into the diabetes treatment plan, patients can strive to better regulate their glycemic levels and improve their overall health.

Type 2 diabetes is a long-term health condition that affects how the body uses insulin. It can result from inadequate insulin production or resistance to insulin's effects. Typically seen in middle-aged or older individuals, it is also known as adult-onset diabetes. Symptoms may include increased thirst, frequent night urination, slow wound healing, fatigue, hunger, and blurred vision. Complications of type 2 diabetes can impact various parts of the body such as nerves, kidneys, eyes, limbs, and increase the risk of heart attack or stroke. Weight changes may also occur in some cases.

Seek medical attention if you have type 1 diabetes mellitus, diabetic ketoacidosis, uncontrolled diabetes with certain symptoms such as nausea, vomiting, rapid weight loss, diarrhea, lactic acidosis, or ketoacidosis. Avoid taking Glimisave M1 750 Tablet PR if you are dehydrated or have a severe infection affecting your lungs or kidneys. Before starting, consult your doctor if you are recovering from injury, surgery, fever, or stress, have G6PD deficiency, or factors that may lead to low blood sugar levels. It is important to seek medical advice in these situations to ensure your safety and health.

Glimisave M1 750 Tablet PR may cause some side effects, but not everyone will experience them. Most side effects are usually mild and go away as your body gets used to the medicine. Common side effects of Glimisave M1 750 Tablet PR include headache, nausea, diarrhea, stomach pain, and a metallic taste in the mouth. Additionally, it may lead to low blood sugar levels (hypoglycemia), which can cause symptoms like weakness, dizziness, sweating, and confusion. In some cases, it may result in changes in blood cell counts or decreased vitamin B12 levels. Skin reactions such as rashes, redness, itching, or hives are also possible side effects of this medication.

If any of the following severe side effects occur, it is crucial to stop taking Glimisave M1 750 Tablet PR and seek immediate medical help: lactic acidosis (buildup of lactic acid in the blood), liver inflammation leading to jaundice (yellowing of the skin or eyes), and severe allergic reactions that can manifest as skin rash, hives, or increased sensitivity to the sun. Severe low blood sugar levels, including loss of consciousness or seizures, are also rare but serious side effects that require immediate medical attention.

If you experience any of these severe side effects, contact your doctor right away. It's essential to monitor your body's response to Glimisave M1 750 Tablet PR and report any unusual symptoms to your healthcare provider for proper evaluation and management.

Glimisave M1 750 Tablet PR is not recommended for use in elderly patients (aged 75 years or above) and it should be used with caution in elderly patients (aged 65 years or above), especially in patients with impaired kidney function. Your doctor may assess your kidney function more frequently during treatment with Glimisave M1 750 Tablet PR. Consult your doctor before taking Glimisave M1 750 Tablet PR.

Glimisave M1 750 Tablet PR is generally not recommended for use in children and adolescents (under 18 years of age). Consult child’s doctor for advice.

Before taking Glimisave M1 750 Tablet PR, it is important to consider the following warnings. Inform your doctor if you have any allergies to this medication or other medicines. This tablet is not suitable for children, and breastfeeding should be avoided while using it as it can be passed through human milk. If you are pregnant or planning to become pregnant, consult your doctor beforehand to prevent harm to the unborn baby. Do not consume alcohol with this medication, as it can increase the risk of lactic acidosis. Only drive if you are fully alert after taking the tablet. Make sure to eat short, frequent meals and avoid prolonged fasting. Be vigilant for symptoms of hypoglycemia such as sweating, dizziness, palpitations, and intense thirst. Keep candies, glucose biscuits, or sugar handy to manage these symptoms and seek medical advice promptly. Carry these supplies with you, especially during long journeys.

If you happen to forget to take a dose of Glimisave M1 750 Tablet PR, try to take it as soon as you remember. However, if it is close to the time for your next scheduled dose, it's best to skip the missed dose and resume your regular dosing schedule. Remember not to double up on the dose to make up for the missed one. It's important to stay consistent with your medication routine for the best results.

In case of taking an excessive amount of Glimisave M1 750 Tablet PR, it is crucial to seek immediate medical assistance by contacting your doctor or heading to the nearest hospital right away. Overdosing on Glimisave M1 750 Tablet PR can lead to serious consequences, such as the risk of experiencing dangerously low blood sugar levels and potentially life-threatening lactic acidosis. Symptoms of lactic acidosis may manifest as vomiting, abdominal pain accompanied by muscle cramps, a pervasive sense of unwellness coupled with extreme fatigue, decreased body temperature, slow heartbeat, and breathing difficulties. If you suspect an overdose or observe any of these symptoms, prompt medical intervention is essential to address the situation effectively.

Related Lab Tests for monitoring the effects of Glimisave M1 750 Tablet PR include Glucose - Fasting Blood test, Glucose - Postprandial Blood test, and Glycosylated Hemoglobin test. These tests are essential for assessing how well the medication is helping to manage blood sugar levels.

- Glucose - Fasting Blood test measures the amount of sugar in the blood after fasting for at least 8 hours, providing a baseline measurement of blood sugar levels.

- Glucose - Postprandial Blood test measures blood sugar levels 2 hours after eating, giving insight into how the body processes sugar after a meal.

- Glycosylated Hemoglobin test, also known as Hemoglobin A1c test, shows the average blood sugar levels over the past 2-3 months, offering a long-term indicator of blood sugar control.

Regular monitoring of these lab tests will help healthcare providers track the effectiveness of Glimisave M1 750 Tablet PR in managing diabetes and adjust treatment as needed.